Asian markets ended mixed on Thursday amid profit booking and as some of the regional markets were closed early for New Year's Eve, while the market remained supported after UK regulators approved a Covid-19 vaccine developed by AstraZeneca and the University of Oxford for emergency use. Chinese shares rose for a second straight day after its factory activity expanded in December. The country’s official manufacturing Purchasing Managers’ Index (PMI) for December came in at 51.9, according to data from the National Bureau of Statistics.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3473.07 | 58.62 | 1.72 |
Hang Seng | 27231.13 | 84.02 | 0.31 |
Jakarta Composite | -- | -- | -- |
KLSE Composite | 1627.21 | -17.20 | -1.05 |
Nikkei 225 | -- | -- | -- |
Straits Times | 2843.81 | -25.41 | -0.89 |
KOSPI Composite | -- | -- | -- |
Taiwan Weighted | 14732.53 | 44.83 | 0.31 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: